AAAAAA
Results:
1-14
|
Results: 14
Authors:
Falco, C
Tormo, G
Estelles, A
Espana, F
Tormo, E
Gilabert, J
Velasco, JA
Aznar, J
Citation: C. Falco et al., Fibrinolysis and lipoprotein(a) in women with coronary artery disease. Influence of hormone replacement therapy, HAEMATOLOG, 86(1), 2001, pp. 92-98
Authors:
Estelles, A
Dalmou, J
Falco, C
Berbel, O
Castello, R
Espana, F
Aznar, J
Citation: A. Estelles et al., Plasma PAI-1 levels in obese children - Effect of weight loss and influence of PAI-1 promoter 4G/5G genotype, THROMB HAEM, 86(2), 2001, pp. 647-652
Authors:
Mezzano, D
Espana, F
Panes, O
Medina, P
Pais, E
Marshall, G
Tagle, R
Downey, P
Caceres, S
Gonzalez, F
Quiroga, T
Pereira, J
Citation: D. Mezzano et al., Increased activation of protein C, but lower plasma levels of free, activated protein C in uraemic patients: relationship with systemic inflammation and haemostatic activation, BR J HAEM, 113(4), 2001, pp. 905-910
Authors:
Martinez, M
Espana, F
Royo, M
Vera, CD
Estelles, A
Jimenez-Cruz, JF
Medina, P
Aznar, J
Citation: M. Martinez et al., Prostate-specific antigen complexed to alpha(1)-antichymotrypsin in the early detection of prostate cancer, EUR UROL, 38(1), 2000, pp. 85-90
Authors:
Segui, R
Estelles, A
Mira, Y
Espana, F
Villa, P
Falco, C
Vaya, A
Grancha, S
Ferrando, F
Aznar, J
Citation: R. Segui et al., PAI-1 promoter 4G/5G genotype as an additional risk factor for venous thrombosis in subjects with genetic thrombophilic defects, BR J HAEM, 111(1), 2000, pp. 122-128
Authors:
Aznar, J
Villa, P
Espana, F
Citation: J. Aznar et al., Functional diagnosis of activated protein C resistance in patients with antiphospholipid antibodies, CL APPL T-H, 5(2), 1999, pp. 139-140
Authors:
Espana, F
Villa, P
Mira, Y
Grancha, S
Royo, M
Estelles, A
Vaya, A
Aznar, J
Citation: F. Espana et al., Factor V Leiden and antibodies against phospholipids and protein S in a young woman with recurrent thromboses and abortion, HAEMATOLOG, 84(1), 1999, pp. 80-84
Authors:
Villa, P
Aznar, J
Vaya, A
Espana, F
Ferrando, F
Mira, Y
Estelles, A
Citation: P. Villa et al., Hereditary homozygous heparin cofactor II deficiency and the risk of developing venous thrombosis, THROMB HAEM, 82(3), 1999, pp. 1011-1014
Authors:
Grancha, S
Estelles, A
Tormo, G
Falco, C
Gilabert, J
Espana, F
Cano, A
Segui, R
Aznar, J
Citation: S. Grancha et al., Plasminogen activator inhibitor-1 (PAI-1) promoter 4G/5G genotype and increased PAI-1 circulating levels in postmenopausal women with coronary arterydisease - Influence of hormone replacement therapy, THROMB HAEM, 81(4), 1999, pp. 516-521
Authors:
Estelles, A
Cano, A
Falco, C
Espana, F
Gilabert, J
Grancha, S
Aznar, J
Citation: A. Estelles et al., Lipoprotein(a) levels and isoforms and fibrinolytic activity in postmenopause - Influence of hormone replacement therapy, THROMB HAEM, 81(1), 1999, pp. 104-110
Authors:
Espana, F
Sanchez-Cuenca, J
Fernandez, PJ
Gilabert, J
Romeu, A
Estelles, A
Royo, M
Muller, CH
Citation: F. Espana et al., Inhibition of human sperm-zona-free hamster oocyte binding and penetrationby protein C inhibitor, ANDROLOGIA, 31(4), 1999, pp. 217-223
Authors:
Espana, F
Royo, M
Martinez, M
Enguidanos, MJ
Vera, CD
Estelles, A
Aznar, J
Jimenez-Cruz, JF
Heeb, MJ
Citation: F. Espana et al., Free and complexed prostate specific antigen in the differentiation of benign prostatic hyperplasia and prostate cancer: Studies in serum and plasma samples - Reply, J UROL, 162(2), 1999, pp. 503-503
Authors:
Schwartz, BS
Espana, F
Citation: Bs. Schwartz et F. Espana, Two distinct urokinase-serpin interactions regulate the initiation of cellsurface-associated plasminogen activation, J BIOL CHEM, 274(21), 1999, pp. 15278-15283
Authors:
Speekenbrink, RGH
Bertina, RM
Espana, F
Wildevuur, CRH
Eijsman, L
Citation: Rgh. Speekenbrink et al., Activation of the protein C system during cardiopulmonary bypass with and without aprotinin, ANN THORAC, 66(6), 1998, pp. 1998-2002
Risultati:
1-14
|